Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral paclitaxel plus S-1 for HER2-negative advanced gastric cancer
ChiCTR2500107270Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel and tegafur in gastric cancer (GC), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Progression-Free Survival and Overall Survival. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
paclitaxeltegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2500107270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107270.